Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2010
11/18/2010WO2010131738A1 Azetidine compound and medicinal use thereof
11/18/2010WO2010131717A1 Prion protein structure transformation inhibitor and utilization of same
11/18/2010WO2010131712A1 Therapeutic pharmaceutical agent for diseases associated with decrease in function of gne protein, food composition, and food additive
11/18/2010WO2010131703A1 NOVEL PPARγ PROMOTER SEQUENCE AND USE APPLICATION THEREOF
11/18/2010WO2010131695A1 Modified double-stranded rna
11/18/2010WO2010131663A1 Oxamide derivative
11/18/2010WO2010130063A1 The little molecule compound which used for promoting the stem cells hyperplasia and the use thereof
11/18/2010WO2010111533A3 Transdermal delivery of pkc modulatory peptides through microporated skin
11/18/2010US20100292500 Npy y5 antagonist
11/18/2010US20100292456 Rna interference mediating small rna molecules
11/18/2010US20100292299 Nucleotide Motifs Providing Localization Elements and Methods of Use
11/18/2010US20100292291 Formulations of deacetylase inhibitors
11/18/2010US20100292205 Pyrimidone Compounds As GSK-3 Inhibitors
11/18/2010US20100292168 Protein Mixture and Use Thereof in the Preparation of a Product that is Intended for Oral or Enteral Administration
11/18/2010US20100291250 Use of an active ingredient that is obtained from cyperus esculentus for its anti-aging cutaneous action
11/18/2010US20100291219 Methods and compositions relating to progenitor cells
11/18/2010US20100291210 Novel lipid peptide and hydrogel
11/18/2010US20100291203 Opioid Agonist/Antagonist Combinations
11/18/2010US20100291202 Coated pharmaceutical or nutraceutical preparation with enhanced pulsed active substance release
11/18/2010US20100291183 Enhanced moisture barrier immediate release film coating systems and substrates coated therewith
11/18/2010US20100291069 Methods of treating a diabetic embryopathy
11/18/2010US20100291059 Pharmaceutical composition for enzyme replacement therapy
11/18/2010US20100291056 Pharmaceutical Compositions Comprising Prasugrel and Cyclodextrin Derivatives and Methods of Making and Using the Same
11/18/2010US20100291047 Use of Mesenchymal Stem Cells for Treating Genetic Disease and Disorders
11/18/2010US20100291026 Piperidine inhibitors of janus kinase 3
11/18/2010US20100290995 Radio-opaque compounds, compositions containing same and methods of their synthesis and use
11/18/2010US20100290994 O-Methylated Rapamycin Derivatives For Alleviation And Inhibition Of Lymphoproliferative Disorders
11/18/2010US20100290991 Novel [f-18]-labelled l-glutamic acid and l-glutamine derivatives (i), their use and processes for their preparation
11/18/2010US20100290985 Macromolecular compositions that cross the blood-brain barrier and methods of use thereof
11/17/2010EP2251426A1 Mammalian-type glycosylation in plants
11/17/2010EP2251344A1 Formulation of boronic acid compounds
11/17/2010EP2251328A1 Crystalline 1-(3-fluorophenyl)-5-methyl-2-(1h)pyridone, the preparation methods, compositions and applications thereof
11/17/2010EP2251326A1 Heterocyclic compound
11/17/2010EP2251039A2 Oligo double-stranded rna inhibiting the expression of bcl-2 and pharmaceutical composition containing the same
11/17/2010EP2251024A1 Plant-origin drug for preventing or improving hyperuricemia
11/17/2010EP2251014A1 Combined use of cholestanol derivative
11/17/2010EP2251011A1 Solid preparation for oral administration
11/17/2010EP1547577B1 Antiaging composition
11/17/2010EP1181358B1 Methods and materials for generating sh3 domains with tailored binding properties
11/17/2010EP0773940B2 Process for synthesis of substituted sulphoxides
11/17/2010CN1863784B 2-naphthylimino-1,3-thiazine derivative
11/17/2010CN101884784A Bv8 nucleic acids and polypeptides with mitogenic activity
11/17/2010CN101884780A Use of hepcidin as a regulator of iron homeostasis
11/17/2010CN101884778A Preparation for eliminating insufficiency of spleen and edema
11/17/2010CN101884745A Chinese medicinal preparation for treating spontaneous sweating and night sweat
11/17/2010CN101884732A Powder for treating abdominal furuncul osis
11/16/2010US7834237 Membrane-localisable fusion protein of an aggregating portion induced through conformational polymerisation
11/16/2010US7834182 histamine H3 receptor antagonists; metabolic disorders, sleep disorders, cardiovascular disorders, alcoholism, drug addiction, memory disorders, Alzheimer's, Parkinson's disease; 2-(4-piperidinylpiperidinyl)pyrimidine compounds such as 2-[(4-piperidin-1-yl)piperidin-1-yl]-5-(3-pyridyl)pyrimidine
11/16/2010US7834180 contacting a picolinic acid derivative with a benzothiazole derivative or tautomers thereof, in the presence of a non-nucleophilic base; compounds inhibit cell proliferation, induce cell apoptosis and stabilize a quadruplex structure
11/16/2010US7834053 2-[[3-(2-benzo[b]thiophen-5-yl-ethoxy)propyl](methyl)amino]-1-ethanol; antihypoxic agent; synergistic mixture with acetylcholine esterase inhibitor (Tacrine, Donepezil, Rivastigmine); neurodegenerative diseases, ischemic cerebral lesion, cerebral apoplexy, Alzheimer's disease, cognition activator
11/16/2010US7834033 administering a tumor necrosis factor inhibitor; angiogenesis inhibitor; treating inflammatory, and autoimmune diseases
11/16/2010US7834006 antidiabetics; lower blood glucose levels; compounds based on 1H,2H,3H,4H,5H,6H,7H,8H-pyrrolo[3,4-e][1,4]diazepin-6-one
11/16/2010US7833972 Proteins and use thereof
11/16/2010US7833742 Fabry disease; X-linked inherited lysosomal storage disease characterized by severe renal impairment, angiokeratomas, and/or cardiovascular abnormalities; selecting a human alpha -Gal A preparation having a desired pharmacokinetic parameter
11/16/2010US7833717 Using neisserial surface protein nucleotide sequences as tool in detection, prevention and treatment of microorganismal infection; immunodiagnostics; immunotherapeutics; vaccine development
11/16/2010US7833537 administering isolated and purified T. suis helminthic parasite preparation free of human bacterial, mycobacterial and viral pathogens; treating inflammatory bowel disease, crohn's disease, and ulcerative colitis, rheumatoid arthritis, type 1 diabetes mellitus, lupus erythematosis, sarcoidosis
11/16/2010US7833525 Crystals of whole antibodies and fragments thereof and methods for making and using them
11/16/2010US7833521 Admnistering a fusion protein of interferon and albumin or an albumin variant, having a higher plasma stability than unfused interferon; albumin or variant is located either at the N-terminus or C-terminus of the fusion protein, fusion protein retains the therapeutic activity of unfused interferon
11/16/2010CA2532714C Oral sustained-release tablet comprising 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide
11/16/2010CA2523216C Recombinant alphavirus vectors
11/16/2010CA2479084C Vdac regulator
11/16/2010CA2477474C Cyclic n-substituted alpha imino carboxylic acids for selective inhibition of collagenase
11/16/2010CA2471220C Novel alkansulfonamides as endothelin antagonists
11/16/2010CA2455621C Use of (r/s)-(-/+) or (s)-(+)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chromane for the treatment of extrapyramidal movement disorders
11/16/2010CA2452114C Tgf-.beta. superfamily production/secretion promoter
11/16/2010CA2436846C Thioether substituted imidazoquinolines
11/16/2010CA2429205C Dermatological formulations
11/16/2010CA2427548C Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them
11/16/2010CA2415643C Pharmaceutical composition for oral use with improved absorption
11/16/2010CA2407316C Pet food composition for reducing inflammatory response in cats
11/16/2010CA2405479C Method of inhibiting the expression of inflammatory cytokines and chemokines
11/16/2010CA2396824C Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2
11/16/2010CA2389165C Substituted indoles for modulating nfkb activity
11/16/2010CA2367240C Treatment of accidental extravasation of anthracyclines
11/16/2010CA2311648C Ifnar2/ifn complex
11/16/2010CA2278151C Heregulin variants
11/16/2010CA2240339C [3'-desoxy-3'-oxo-mebmt]1-[val]2-ciclosporin-containing emulsion pharmaceutical composition
11/11/2010WO2010128672A1 Neovascularization inducer comprising genetically recombined gelatin
11/11/2010WO2010128663A1 Interleukin-2 production inhibitor
11/11/2010WO2010128659A1 Diamino heterocyclic carboxamide compound
11/11/2010WO2010128158A1 Diagnostic biomarkers for fibrotic disorders
11/11/2010WO2010127600A1 6-deoxidized sulfone cyclodextrin derivatives and preparation method thereof
11/11/2010WO2010127557A1 Use of lanostanes and extracts from poria cocos for treating cachexia
11/11/2010WO2010127411A1 Treatment of pain and/or inflammation and treatment and prevention of a skin or mucosal disease and/or condition
11/11/2010US20100287626 Method of screening ptp zeta activity promoter or inhibitor
11/11/2010US20100286386 Combinatorial production of nucleotide and nucleoside (XiTP) analogues
11/11/2010US20100286255 Method for extracting secoisolariciresinol and dihydroquercetin from wood
11/11/2010US20100286253 Method for treating ocular neovascularization
11/11/2010US20100286235 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals
11/11/2010US20100286223 Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors
11/11/2010US20100286218 Liquid preservative compositions
11/11/2010US20100286197 Carboxamide Derivatives As Therapeutic Agents
11/11/2010US20100286186 Novel dicarboxylic acid linked amino acid and peptide prodrugs of opioids and uses thereof
11/11/2010US20100286063 GNRH agonist combination drugs
11/11/2010US20100286057 Methods and compositions for modulating bcl-2 family polypeptides
11/11/2010US20100286042 Medicinal Composition Containing Highly Functionalized Chimeric Protein
11/11/2010US20100285147 Crude drug extract-blended liquid medicine
11/11/2010US20100285128 Space filled drug release structure and method of manufacturing the same
11/11/2010US20100285100 Compositions and medical devices for controlled release of nitric oxide and methods of production thereof
11/11/2010US20100285097 Vaginal delivery system
1 ... 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 ... 1564